Science Explorer Back to mapMap
Discussion
Company · Charleroi · Belgium

Bone Therapeutics

bonetherapeutics.com/enROR OpenAlex
Research works
59
▼ 17% vs 2018-21
Citations
388
6.6 per fractional work
Top-10% rate
13.7%
all institutions 10.0%
Open access
35%
world 40%
International
34%
world 18%
Bone Therapeutics

Not ranked overall: Bone Therapeutics is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Bone Therapeutics work in?

In 2022-now, 60% of research at Bone Therapeutics is in Life Sciences, 36% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (40%), Medicine (35%), Immunology and Microbiology (12%). It does 2.7× the world's share of Life Sciences.

Life Sciences: 13 fractional works · 59.7% of its workBiochemistry, Genetics and Molecular Biology: 9 fractional works · 40.1% of its workMolecular Biology: 5 fractional works · 24.8% of its workCancer Research: 1 fractional works · 6.5% of its workPhysiology: 1 fractional works · 5.4% of its workGenetics: 0 fractional works · 1.4% of its workBiophysics: 0 fractional works · 1.1% of its workCell Biology: 0 fractional works · 0.5% of its workClinical Biochemistry: 0 fractional works · 0.4% of its workImmunology and Microbiology: 3 fractional works · 12.0% of its workImmunology: 2 fractional works · 10.0% of its workApplied Microbiology and Biotechnology: 0 fractional works · 1.5% of its workMicrobiology: 0 fractional works · 0.5% of its workNeuroscience: 2 fractional works · 7.6% of its workNeurology: 1 fractional works · 2.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 2.0% of its workEndocrine and Autonomic Systems: 0 fractional works · 2.0% of its workCognitive Neuroscience: 0 fractional works · 0.5% of its workSensory Systems: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workHealth Sciences: 8 fractional works · 36.0% of its workMedicine: 8 fractional works · 35.0% of its workOncology: 2 fractional works · 10.2% of its workPulmonary and Respiratory Medicine: 2 fractional works · 6.8% of its workEpidemiology: 1 fractional works · 2.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.6% of its workSurgery: 0 fractional works · 2.0% of its workPsychiatry and Mental health: 0 fractional works · 1.9% of its workNeurology: 0 fractional works · 1.5% of its workHematology: 0 fractional works · 1.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.1% of its workPhysiology: 0 fractional works · 1.1% of its workGenetics: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.8% of its workPathology and Forensic Medicine: 0 fractional works · 0.7% of its workInfectious Diseases: 0 fractional works · 0.5% of its workGastroenterology: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workNursing: 0 fractional works · 1.0% of its workNutrition and Dietetics: 0 fractional works · 1.0% of its workPhysical Sciences: 1 fractional works · 4.4% of its workChemistry: 1 fractional works · 3.7% of its workOrganic Chemistry: 1 fractional works · 3.0% of its workSpectroscopy: 0 fractional works · 0.6% of its workEnvironmental Science: 0 fractional works · 0.3% of its workEcology: 0 fractional works · 0.3% of its workEngineering: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.1% of its workALL ITS WORKBone Therapeutics22fractional works, 2022-now
Life Sciences60%Physical Sciences4%Health Sciences36%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 10 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology940.1%
    2. Immunology and Microbiology312.0%
    3. Neuroscience27.6%
    1. Medicine835.0%
    2. Nursing01.0%
    1. Chemistry13.7%
    2. Environmental Science00.3%
    3. Engineering00.2%
    4. Computer Science00.1%
    5. Materials Science00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.51× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 11.89× its world share, 3 worksImmunology and Micro…Neuroscience: 4.72× its world share, 2 worksNeuroscienceChemistry: 2.33× its world share, 1 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEngineering: 0.01× its world share, 0 worksEngineeringEnvironmental Science: 0.05× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.04× its world share, 0 worksMaterials ScienceMedicine: 1.82× its world share, 8 worksMedicineNursing: 2.05× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.9×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Immunology and Microbiology11.89×3 works
  2. Biochemistry, Genetics and Molecular Biology7.51×9 works
  3. Neuroscience4.72×2 works
  4. Chemistry2.33×1 works
  5. Nursing2.05×0 works
  6. Medicine1.82×8 works
  7. Environmental Science0.05×0 works
  8. Materials Science0.04×0 works
  9. Computer Science0.02×0 works
  10. Engineering0.01×0 works

Who are the top researchers at Bone Therapeutics?

Ranked on the quality score, Grégory Driessens, Shruthi Prasad and Marjorie Mercier lead among researchers whose main affiliation is Bone Therapeutics.

  1. 1 Grégory Driessens Belgium · #606,008 worldwide 3.3k citations · 80 works
  2. 2 Shruthi Prasad Belgium · #837,024 worldwide 530 citations · 58 works
  3. 3 Marjorie Mercier Belgium · #1,226,645 worldwide 648 citations · 51 works
  4. 4 Erica Houthuys Belgium · #1,364,406 worldwide 845 citations · 38 works
  5. 5 Hussein Shehade Belgium · #1,473,186 worldwide 558 citations · 37 works
  6. 6 João Marchante Belgium · #1,946,203 worldwide 134 citations · 22 works
  7. 7 Reece G. Marillier Belgium · #2,164,964 worldwide 583 citations · 53 works
  8. 8 Catherine Hoofd Belgium · #2,278,745 worldwide 310 citations · 33 works
  9. 9 Noémie Wald Belgium · #2,357,980 worldwide 621 citations · 38 works
  10. 10 Julie Preillon Belgium · #2,807,747 worldwide 366 citations · 36 works
All ranked researchers at Bone Therapeutics

What are the most cited papers from Bone Therapeutics?

The most cited paper from Bone Therapeutics is "Bone density and antiepileptic drugs: a case-controlled study" (Linda J. Stephen, A. R. McLellan, Joyce Harrison et al., 1999), with 159 citations. Next come "Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1 H -indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate" (142) and "Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study" (94).

Most cited papers
#PaperReleasedCitations
1 Bone density and antiepileptic drugs: a case-controlled study Linda J. Stephen, A. R. McLellan, Joyce Harrison et al. · Seizure Open access Sep 1999 159
2 Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1 H -indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate Stefano Crosignani et al. · Journal of Medicinal Chemistry Open access 7 Nov 2017 142
3 Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study On behalf of the Italian Melanoma Intergroup (IMI) et al. · Cancer Immunology Immunotherapy Open access 11 Oct 2018 94
4 Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy Bruno Mattiello Gomes et al. · Molecular Cancer Therapeutics Open access 20 Sep 2018 85
5 Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors Florence Schramme, Stefano Crosignani, Kim Frederix et al. · Cancer Immunology Research Open access 5 Dec 2019 71
All 85 most cited papers, with filters and sorting

Which keywords describe research at Bone Therapeutics?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer, Tumor Microenvironment, Inflammation, Therapeutic Targets, Oxidative Stress, Metabolism, Epigenetic Regulation and Immune Suppression.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Cancer4▲ 12×10 topics
  2. Inflammation3▲ 6.8×9 topics
  3. Tumor Microenvironment3▲ 32×5 topics
  4. Oxidative Stress2▲ 5.7×8 topics
  5. Therapeutic Targets2▲ 54×3 topics
  6. Metabolism2▲ 14×4 topics
  7. Epigenetic Regulation1▲ 29×2 topics
  8. Immune Suppression1▲ 115×2 topics
  9. Adenosine Receptors1▲ 336×1 topic
  10. Mitochondrial Dysfunction1▲ 19×6 topics
  11. Neuroprotection1▲ 16×2 topics
  12. Purinergic Signalling1▲ 336×1 topic
  13. Transcriptional Regulation1▲ 32×4 topics
  14. Immune Checkpoint Blockade1▲ 40×1 topic
  15. Neurodegeneration1▲ 15×4 topics
  16. PD-1 and PD-L11▲ 40×1 topic
  17. Redox Regulation1▲ 263×2 topics

Which research topics does Bone Therapeutics publish most on?

By volume in 2022-now: Adenosine and Purinergic Signaling, Cancer Immunotherapy and Biomarkers, RNA modifications and cancer and Cancer-related molecular mechanisms research.

Adenosine and Purinergic…1Adenosine and Purinergic Signaling: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksRNA modifications and cancer: 1 fractional worksCancer-related molecular mechanisms research: 1 fractional worksImmune Cell Function and…1Immune Cell Function and Interaction: 1 fractional worksCancer-related gene regulation: 1 fractional worksRedox biology and oxidative stress: 1 fractional worksSynthesis and biological…1Synthesis and biological activity: 1 fractional worksPI3K/AKT/mTOR signaling in cancer: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional works
PhysiologyOncologyMolecular BiologyCancer Research3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Adenosine and Purinergic Signaling Physiology 1 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
  3. 3 RNA modifications and cancer Molecular Biology 1 works
  4. 4 Cancer-related molecular mechanisms research Cancer Research 1 works
  5. 5 Immune Cell Function and Interaction Immunology 1 works
  6. 6 Cancer-related gene regulation Molecular Biology 1 works
  7. 7 Redox biology and oxidative stress Molecular Biology 1 works
  8. 8 Synthesis and biological activity Organic Chemistry 1 works
  9. 9 PI3K/AKT/mTOR signaling in cancer Molecular Biology 1 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.3%not open64.7%

World: 40% of research is openly available.

with international co-authors34.2%domestic only65.8%

World: 18% is written across borders.

How has Bone Therapeutics's research output changed?

Output in 2022-2025 was 17% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Bone Therapeutics as a percentage of every work published that year, 0.00011% in 2024.

still counting0.00020%0.00040%Bone Therapeutics0.00012% in 2025200020102020

Fractional works of Bone Therapeutics over all fractional works that year. How the balance of science has shifted.

Other research institutions in Charleroi

All research institutions in Charleroi

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Bone Therapeutics. Posts are plain text and can be reported.